Minsi Li
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
-
- Nanoparticle-Based Drug Delivery 5
-
- Nanoplatforms for cancer theranostics 3
- Graphene and Nanomaterials Applications 1
- Co-authors
- Chuanchuan He (9 shared papers)Pengxuan Zhao (9 shared papers)Guangya Xiang (9 shared papers)Yao Lu (8 shared papers)Xiaojuan Zhang (7 shared papers)Robert J. Lee (7 shared papers)Tan Yang (6 shared papers)Ruicong Yan (5 shared papers)
- Journals
- International Journal of Pharmaceutics (3 papers)Biomaterials Science (1 paper)Scientific Reports (1 paper)Acta Pharmaceutica Sinica B (1 paper)Lubricants (1 paper)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Minsi Li
11 papers receiving 437 citations
Peers
Comparison fields: 5 of 62
- Biomaterials 184
- Molecular Medicine 36
- Cancer Research 87
- Biomedical Engineering 180
- Pharmaceutical Science 23
Countries citing papers authored by Minsi Li
This map shows the geographic impact of Minsi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minsi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minsi Li more than expected).
Fields of papers citing papers by Minsi Li
This network shows the impact of papers produced by Minsi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minsi Li. The network helps show where Minsi Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Minsi Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 82 | |
| 2 | 2018 | 74 | |
| 3 | 2019 | 57 | |
| 4 | 2018 | 53 | |
| 5 | 2017 | 53 | |
| 6 | 2019 | 41 | |
| 7 | 2020 | 36 | |
| 8 | 2019 | 20 | |
| 9 | 2019 | 12 | |
| 10 | 2024 | 6 | |
| 11 | 2023 | 4 |
About Minsi Li
Minsi Li is a scholar working on Biomaterials, Biomedical Engineering, Molecular Biology, Pathology and Forensic Medicine and Oncology, having authored 11 papers that have together received 438 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (3 papers), Cancer Mechanisms and Therapy (2 papers), RNA Interference and Gene Delivery (2 papers), Selenium in Biological Systems (1 paper), Ferroptosis and cancer prognosis (1 paper), Advanced Nanomaterials in Catalysis (1 paper) and Graphene and Nanomaterials Applications (1 paper). The work is most often cited by research in Biomaterials (184 citations), Molecular Medicine (36 citations), Cancer Research (87 citations), Biomedical Engineering (180 citations) and Pharmaceutical Science (23 citations). Minsi Li has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Chuanchuan He, Pengxuan Zhao, Guangya Xiang, Yao Lu, Xiaojuan Zhang, Robert J. Lee, Tan Yang, Ruicong Yan, Ting Fan and Xiang Ma. Their work appears in journals such as International Journal of Pharmaceutics, Biomaterials Science, Scientific Reports, Acta Pharmaceutica Sinica B and Lubricants.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.